NCT04799444 (LATE-COVID) is a clinical trial in Covid19, sponsored by Polish Mother Memorial Hospital Research Institute.

Who is sponsoring NCT04799444?

NCT04799444 is sponsored by Polish Mother Memorial Hospital Research Institute.

Is NCT04799444 still recruiting?

NCT04799444 is currently status unknown. Last updated 16 March 2021.

Last reviewed 2021-03-16 · How we verify

NCT04799444: LATE-COVID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults

Status unknown Last updated 16 March 2021

What this trial tests

trial in Covid19 in 500 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Polish Mother Memorial Hospital Research Institute
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 October 2020
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Poland

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Polish Mother Memorial Hospital Research Institute

Who can join

Eligibility, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All consecutive patients admitted to the Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland between 1st October 2020 and 31st December 2021 due to symptoms, which might reflect complications following COVID-19, will be included in the observational cohort study. Data concerning clinical characteristics, results of laboratory tests, other studies, such as: echocardiography, 24 hours ambulatory ECG recording will be collected. The study is planned also to be extended with the genetic predisposition in children to COVID-19 late complications (within independent grant).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study.
Jatczak-Pawlik I, Lewek J, Czkwianianc E, Blomberg A, et al · · 2022 · cited 5× · PMID 35316904 · DOI 10.5114/aoms/146827
Factors influencing the risk of cardiovascular complications following COVID-19 - clinical implications. The LATE-COVID study.
Lewek J, Sosnowska B, Bielecka-Dąbrowa A, Banach M. · · 2025 · PMID 41676417 · DOI 10.5114/aoms/188090

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Polish Mother Memorial Hospital Research Institute trials

Trials by the same sponsor.

NCT06889376 — Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination. · Phase 1 · not yet recruiting
NCT05763108 — Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes · completed
NCT05180123 — Clinical and MRI Evaluation of ACL Reconstruction Results in Adolescents With Follow-up at Least 3 Years. · NA · recruiting
NCT05184439 — Evaluation of Adductor Magnus Tenodesis in Patients With Recurrent Patellar Dislocation. · completed
NCT04987983 — A Comparison Study of Feeding Prematures in the Side-lying Position on the Right and Left Side - a Pilot Study. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04799444 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Polish Mother Memorial Hospital Research Institute
Last refreshed: 16 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04799444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing